Targeting Glioblastoma Tumor Microenvironment.

Area of Science:

• Neuro-oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Glioblastoma multiforme (GBM) is a highly aggressive brain cancer with a poor prognosis.
• GBM treatment is challenging due to the phenotypic variations of neural stem cells.
• The tumor microenvironment (TME) significantly influences these cellular variations.

Purpose of the Study:

• To provide a comprehensive review of the critical components constituting the GBM TME.
• To explore emerging therapeutic strategies targeting key areas within the TME.

Main Methods:

• Review of existing literature on GBM and TME.
• Analysis of cellular and molecular components of the TME.
• Examination of current and developing therapeutic approaches.

Main Results:

• The TME comprises diverse elements including fibroblasts, immune cells, vascular networks, extracellular matrix, and signaling molecules.
• Phenotypic variations in neural stem cells are intrinsically linked to TME composition.
• Various therapeutic strategies are being developed to target specific TME components.

Conclusions:

• Targeting the TME offers a promising avenue for improving GBM treatment outcomes.
• A deeper understanding of TME dynamics is crucial for advancing GBM therapies.
• Future research should focus on integrated therapeutic approaches targeting multiple TME facets.